Literature DB >> 7615009

CD40 ligand-independent B cell activation revealed by CD40 ligand-deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation.

P Lane1, C Burdet, F McConnell, A Lanzavecchia, E Padovan.   

Abstract

We report the capacity of CD40 ligand (CD40L)-negative T cell clones to activate human B cells. CD40L-negative T cells induce a level of B cell proliferation 10-20% of that seen with normal T cells. The signal provided by the negative clones is synergistic with that derived from a CD40L transfectant, and restores B cell proliferation to normal levels, showing that CD40L-negative T cell clones are not inherently inhibitory for B cells. Although their capacity to induce proliferation was much reduced, CD40L-negative T cell clones were still strong inducers of B cell differentiation to plasma cells. This differentiation to plasma cells was inhibited by a CD40L transfectant. The data are discussed with regard to the normal in vivo mechanism for maintaining B cell memory and memory antibody responses to T-dependent antigens.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615009     DOI: 10.1002/eji.1830250646

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

1.  Short-circuiting long-lived humoral immunity by the heightened engagement of CD40.

Authors:  Loren D Erickson; Brigit G Durell; Laura A Vogel; Brian P O'Connor; Marilia Cascalho; Teruhito Yasui; Hitoshi Kikutani; Randolph J Noelle
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  Comparative analysis of transduced primary human dendritic cells generated by the use of three different lentiviral vector systems.

Authors:  Elena Grabski; Zoe Waibler; Silke Schüle; Björn-Philipp Kloke; Linda Y Sender; Sylvia Panitz; Klaus Cichutek; Matthias Schweizer; Ulrich Kalinke
Journal:  Mol Biotechnol       Date:  2011-03       Impact factor: 2.695

3.  Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12.

Authors:  P Panina-Bordignon; D Mazzeo; P D Lucia; D D'Ambrosio; R Lang; L Fabbri; C Self; F Sinigaglia
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

4.  Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.

Authors:  D D'Ambrosio; M Cippitelli; M G Cocciolo; D Mazzeo; P Di Lucia; R Lang; F Sinigaglia; P Panina-Bordignon
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

5.  Macrophages prevent the differentiation of autoreactive B cells by secreting CD40 ligand and interleukin-6.

Authors:  Michelle A Kilmon; Nikki J Wagner; Alaina L Garland; Li Lin; Katja Aviszus; Lawrence J Wysocki; Barbara J Vilen
Journal:  Blood       Date:  2007-09-01       Impact factor: 22.113

6.  Potential immaturity of the T-cell and antigen-presenting cell interaction in cord blood with particular emphasis on the CD40-CD40 ligand costimulatory pathway.

Authors:  P Han; T McDonald; G Hodge
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

7.  Interleukin-10 secretion differentiates dendritic cells from human liver and skin.

Authors:  Sarah Goddard; Janine Youster; Emma Morgan; David H Adams
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

8.  Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents.

Authors:  Nataša Obermajer; Julie Urban; Eva Wieckowski; Ravikumar Muthuswamy; Roshni Ravindranathan; David L Bartlett; Pawel Kalinski
Journal:  Nat Protoc       Date:  2018-01-18       Impact factor: 13.491

9.  Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus.

Authors:  H B Richards; M Satoh; M Shaw; C Libert; V Poli; W H Reeves
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

10.  Origin and Function of Circulating Plasmablasts during Acute Viral Infections.

Authors:  Katja Fink
Journal:  Front Immunol       Date:  2012-04-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.